Interferon Biology and LAG-3 Shedding in PD-(L)1 plus LAG-3 Immunotherapy

被引：3
作者：
Karapetyan, Lilit [1 ,2 ]
Luke, Jason J. [3 ,4 ,5 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Dept Oncol Sci, Tampa, FL USA
[3] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[5] 5150 Ctr Ave,Room 1 27C, Pittsburgh, PA 15232 USA
来源：
CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 05期
关键词：
CELL; RELATLIMAB; NIVOLUMAB;
D O I：
10.1158/1078-0432.CCR-22-3312
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Targeting coinhibitory receptors on dysfunctional T cells may improve response to anti-PD-(L)1 in the IFNy associated T-cell-inflamed tumor microenvironment. The bispecific lymphocyte activation gene 3 (LAG-3) and PD-L1 blocking antibody FS118, potentially through LAG-3 shedding, represents a promising strategy to improve immune checkpoint blockade. Soluble LAG-3 is an intriguing biomarker for LAG-3 drug activity.
引用
收藏
页码：835 / 837
页数：3
相关论文
共 50 条
  • [31] Impact of LAG-3/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma
    Yoshida, Takashi
    Nakamoto, Takahiro
    Atsumi, Naho
    Ohe, Chisato
    Sano, Takeshi
    Yasukochi, Yoshiki
    Tsuta, Koji
    Kinoshita, Hidefumi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07) : 1 - 14
  • [32] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
    Saleh, Reem
    Toor, Salman M.
    Khalaf, Sarah
    Elkord, Eyad
    VACCINES, 2019, 7 (04)
  • [33] Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands
    Garman, Bradley
    Jiang, Can
    Daouti, Sherif
    Kumar, Sanah
    Mehta, Priyanka
    Jacques, Miye K.
    Menard, Laurence
    Manjarrez-Orduno, Nataly
    Dolfi, Sonia
    Mukherjee, Piali
    Rai, Sharmila Chamling
    Lako, Ana
    Koenitzer, Jennifer D.
    David, Justin M.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [34] Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival Outcome
    Ciraolo, Elisa
    Althoff, Stefanie
    Russ, Josefine
    Rosnev, Stanislav
    Butze, Monique
    Puhl, Miriam
    Frentsch, Marco
    Bullinger, Lars
    Na, Il-Kang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [35] LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
    Kluemper, Niklas
    Ralser, Damian J.
    Bawden, Emma Grace
    Landsberg, Jenny
    Zarbl, Romina
    Kristiansen, Glen
    Toma, Marieta
    Ritter, Manuel
    Hoelzel, Michael
    Ellinger, Joerg
    Dietrich, Dimo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [36] Blockade of PD-1 and LAG-3 expression on CD8+T cells promotes the tumoricidal effects of CD8+T cells
    Ma, Jiajia
    Yan, Shufang
    Zhao, Ying
    Yan, Huifang
    Zhang, Qian
    Li, Xinxia
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
    Huang, Ruea-Yea
    Francois, Ariel
    McGray, A. J. Robert
    Miliotto, Anthony
    Odunsi, Kunle
    ONCOIMMUNOLOGY, 2017, 6 (01):
  • [38] Challenges and prospects of LAG-3 inhibition in advanced gastric and gastroesophageal junction cancer: insights from the RELATIVITY-060 trial
    Seghers, Sofie
    Domen, Andreas
    Prenen, Hans
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (06) : 2735 - 2738
  • [39] Clinical Significance of Expression of Immunoadjuvant Molecules (LAG-3, TIM-3, OX-40) in Neoadjuvant Chemotherapy for Breast Cancer
    Asano, Yuka
    Kashiwagi, Shinichiro
    Takada, Koji
    Ishihara, Sae
    Goto, Wataru
    Morisaki, Tamami
    Shibutani, Masatsune
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2022, 42 (01) : 125 - 136
  • [40] Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
    Andrews, Lawrence P.
    Somasundaram, Ashwin
    Moskovitz, Jessica M.
    Szymczak-Workman, Andrea L.
    Liu, Chang
    Cillo, Anthony R.
    Lin, Huang
    Normolle, Daniel P.
    Moynihan, Kelly D.
    Taniuchi, Ichiro
    Irvine, Darrell J.
    Kirkwood, John M.
    Lipson, Evan J.
    Ferris, Robert L.
    Bruno, Tullia C.
    Workman, Creg J.
    Vignali, Dario A. A.
    SCIENCE IMMUNOLOGY, 2020, 5 (49)
12345